title: Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas?
authors.affiliation: Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA 
authors.forename: Soma
authors.initials: S
authors.lastname: Sengupta
authors.forename: Shyamal D
authors.initials: SD
authors.lastname: Weeraratne
authors.forename: Yoon-Jae
authors.initials: YJ
authors.lastname: Cho
authors.forename: Scott L
authors.initials: SL
authors.lastname: Pomeroy
mesh_terms: D002528:Cerebellar Neoplasms / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D008527:Medulloblastoma / Q000378:metabolism* / Q000628:therapy; D011963:Receptors, GABA-A / Q000378:metabolism*
chemical_list: C527986:GABRA5 protein, human; D011963:Receptors, GABA-A
keywords: H2AX; HOXA5; QH-ii-066 ; medulloblastoma; α5-GABA-A receptor